MYCN and neuroblastoma: Genome-wide surveys have identified a large number of protein biomarkers [6, 7], among which v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) oncogene, is a strong prognostic marker for advance stage NB, indicating a poor survival rate [8–10].